Patent Assignment
Reel/Frame 053231/0843
Change of Name
Recorded: 2020-07-16
Pages: 4
Assignor
ADARE DEVELOPMENT I, L.P.
Executed: 2019-11-25
Assignee
ADARE PHARMACEUTICALS US, L.P.
1200 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Property
(1)
Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 11, 2017
From: GOSSELIN, MICHAEL A.; LAI, JIN-WANG; VENKATESH, GOPI M.
To: APTALIS PHARMATECH INC.
Reel/Frame 042976/0009 →
Assignment of Assignor's Interest
Dec 4, 2018
From: ADARE PHARMACEUTICALS, INC.
To: ADARE DEVELOPMENT I, L.P,
Reel/Frame 047672/0450 →
Security Interest
Dec 18, 2018
From: ADARE DEVELOPMENT I, L.P.
To: BANK OF MONTREAL
Reel/Frame 047807/0967 →
Change of Name
Sep 5, 2019
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 050278/0483 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276
Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →
Change of Name
May 21, 2024
From: ADARE PHARMACEUTICALS US, L.P.
To: ELLODI PHARMACEUTICALS, L.P.
Reel/Frame 067487/0177 →